Results 81 to 90 of about 42,047 (260)
Performance Assessment of FibriTimer™ Zeta-1 for PT and APTT Testing
The FibriTimer™ Zeta-1 (called ZETA1) is a new, semi-automated multipurpose Haemostasis system, indigenously developed featuring DUAL TECHNOLOGY. ZETA1 is designed and developed by a Bangalore MedTech Startup M/S Dfine Bio-innovations Pvt Ltd, keeping in mind the needs of smaller labs.
null Swati Pai, null Sudhindra
openaire +1 more source
ABSTRACT Sodium hypochlorite is a well‐established biocide extensively used in both living and industrial environments; however, exposure to it or improper handling can harm the human body and the environment. Thus, safer alternatives to sodium hypochlorite are required.
Seung Eui Min +3 more
wiley +1 more source
Abstract Introduction This study aims to investigate patient factors affecting the rate of plasma volume target attained in hypertriglyceridemic pancreatitis (HTG‐AP) patients undergoing double filtration plasmapheresis (DFPP). Methods A retrospective analysis of 82 HTG‐AP‐interpreted patients from January 2019 to April 2024 compared target plasma ...
Hui Zhang, Chenqiang Zhu, Yunlong Wu
wiley +1 more source
INDUCTION OF TOLERANCE BY ORAL ADMINISTRATION OF FACTOR VIII AND TREATMENT OF HEMOPHILA [PDF]
Disclosed herein is a simple method for the treatment of antigen-deficiency diseases, by orally administering to a Subject a therapeutically effective amount of the deficient anti gen, wherein the antigen is not present in a liposome.
Alpan, Oral +3 more
core +1 more source
In a randomized cross‐over trial, regional citrate anticoagulation provided superior biocompatibility over full‐dose unfractionated heparin during expanded hemodialysis with significantly lower activation of complement, granulocytes, and platelets without affecting dialysis efficiency. ABSTRACT Background Regional citrate anticoagulation (RCA) improves
Marija Malgaj Vrečko +7 more
wiley +1 more source
PERBEDAAN RERATA FAKTOR HEMOSTASIS PADA PREEKLAMPSIA BERAT DAN EKLAMPSIA
Tujuan : Untuk melihat perbedaan rerata faktor hemostasis pada preeklampsia berat dan eklampsia. Metode : Penelitian yang dilakukan bersifat deskriptif analitik menggunakan desain cross sectional study dengan melihat Rekam Medis subjek sesuai ...
Dyhan Purna Setia +2 more
doaj +1 more source
Identifying which septic patients have increased mortality risk using severity scores:a cohort study [PDF]
Background: Early aggressive therapy can reduce the mortality associated with severe sepsis but this relies on prompt recognition, which is hindered by variation among published severity criteria. Our aim was to test the performance of different severity
Davey, Peter G +5 more
core +4 more sources
Comparison of Rapid Centrifugation Technique with Conventional Centrifugation for Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT) Testing [PDF]
Prothrombin Time (PT) and activated partial thromboplastin time (APTT) are frequently performed coagulation tests in patients with coagulation disorders especially in critical care areas and in monitoring patients on anticoagulation therapy. In coagulation testing, sample processing especially centrifugation is one of the most critical steps that ...
Ekta, Chandler +2 more
openaire +2 more sources
eOGO is an uncommon adverse event in patients on long‐term LVAD support. Thirty‐one eOGO patients were identified in a single‐centre HM3 implantation program. Twenty patients underwent percutaneous stenting. This treatment resulted in immediate LVAD flow improvement and yielded satisfactory quality‐of‐life results, with 62.5% patients assigned a fair ...
Anna Huang +14 more
wiley +1 more source
The Use of Point of Care Testing for Monitoring of APTT in Patients Receiving Heparin Infusion
Background: There is a high risk of thromboembolic events among patients undergoing cardiac surgery, and perioperative anticoagulation is sometimes required. The time taken for laboratory based APTT blood sampling results and adjustments may compromise patient safety.
Surman TL, Worthington MG
openaire +2 more sources

